Clarivate Announces Agenda for 16th Pharmavision India Conference

Clarivate Plc, a leading global provider of transformative intelligence, today announced the theme and agenda of the 16th annual Pharmavision India conference. Scheduled for September 3, 2025, at the Taj Krishna in Hyderabad, the event will convene global pharmaceutical leaders, policymakers, regulators, and industry innovators to examine the forces reshaping the pharmaceutical sector and their impact on India’s life sciences and healthcare industry. Discussions will address profound market shifts, from the wave of blockbuster drug patent expiries to the rise of biosimilars, increasing regulatory demands, evolving U.S. tariff policies, and the urgent need to expand access to affordable medicines. 

As a premier forum for knowledge exchange, Pharmavision India will spotlight India’s growing influence in shaping the global pharma landscape. Leveraging Clarivate’s proprietary data and insights, the conference will aim to inform critical discussions on innovation, regulatory change, market access and supply chain resilience, helping participants identify emerging opportunities and strategies for sustainable growth.

Henry Levy, President, Life Sciences and Healthcare, Clarivate, added: “The upcoming patent cliff, combined with evolving global trade dynamics, will reshape the pharmaceutical landscape. Indian firms, with their cost advantages, regulatory readiness and strategic adaptability, are well-positioned to expand globally and deliver more affordable medicines. Event participants will play a key role in exploring solutions and strategies to capture these opportunities.”

Deepak Sapra, Chief Executive Officer, API and Services, Dr. Reddy’s Laboratories Ltd., said: “Pharmavision India has provided a platform for the pharma, biotech and healthcare sectors in India - bringing together industry leaders to discuss sustainable growth in a competitive and uncertain environment.”

Pharmavision India will spotlight how Indian pharmaceutical companies are advancing from generics leaders to global healthcare partners. Expert speakers and industry leaders will discuss patent expiries, biosimilars, evolving trade policies and strategies to enhance market access, strengthen supply chains and drive global competitiveness. Attendees will explore:

• Strategies to capture opportunities from the global patent cliff and biosimilar expansion

• Pathways to enter and thrive in new and cost-sensitive markets

• Approaches to regulatory readiness 

• Building resilient, competitive supply chains to meet global demand

• Indian success stories that are advancing innovation and improving access to medicines

The conference will underscore how Indian pharmaceutical companies are strengthening their role in the global value chain and contributing to sustainable, innovation-driven healthcare solutions that support long-term global health goals.